End of study sample collection At the end of the study, at experimental day 140, an aliquot of 25 g of excreta sample was collected from each cage and freeze-dried (James Hutton Institute, Aberdeen, UK)
Many researchers report maintaining strength levels throughout their weight loss journey, something that rarely occurs with diet alone
However, unlike branded medicines, these compounds are not FDA-approved because no clinical trials have tested their safety and effectiveness
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown